Shares of ClouDr Group rose sharply in Hong Kong after the Chinese medical software provider said it will integrate AI firm DeepSeek's model into its core product. The stock rose 12% to HK$1.81 in ...
After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).
NICE judged that ‘more data is needed to be certain that these technologies do not incorrectly detect or miss skin cancer in people with black or brown skin’. Skin Analytics s ...
Vijay Pande, PhD, founding investor of Andreessen Horowitz's Bio + Health fund and a general partner with the tech venture capital firm , discusses how AI’s uptake in healthcare will shape its ...
Revolutionary AI breast cancer screening trial launches across 30 UK sites, promising to tackle radiologist shortages and speed up diagnosis for 700,000 women.